{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:19:52Z","timestamp":1792095592160,"version":"4.4.0"},"reference-count":190,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2023,1,20]],"date-time":"2023-01-20T00:00:00Z","timestamp":1674172800000},"content-version":"vor","delay-in-days":19,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009045","name":"Jagiellonian University Medical College","doi-asserted-by":"crossref","award":["N41\/DBS\/000682"],"award-info":[{"award-number":["N41\/DBS\/000682"]}],"id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100009045","name":"Jagiellonian University Medical College","doi-asserted-by":"crossref","award":["N41\/DBS\/00906"],"award-info":[{"award-number":["N41\/DBS\/00906"]}],"id":[{"id":"10.13039\/100009045","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023,3,17]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Fibrinogen conversion into insoluble fibrin and the formation of a stable clot is the final step of the coagulation cascade. Fibrin clot porosity and its susceptibility to plasmin-mediated lysis are the key fibrin measures, describing the properties of clots prepared ex vivo from citrated plasma. Cardiovascular disease (CVD), referring to coronary heart disease, heart failure, stroke, and hypertension, has been shown to be associated with the formation of dense fibrin networks that are relatively resistant to lysis. Denser fibrin mesh characterized acute patients at the onset of myocardial infarction or ischaemic stroke, while hypofibrinolysis has been identified as a persistent fibrin feature in patients following thrombotic events or in those with stable coronary artery disease. Traditional cardiovascular risk factors, such as smoking, diabetes mellitus, hyperlipidaemia, obesity, and hypertension, have also been linked with unfavourably altered fibrin clot properties, while some lifestyle modifications and pharmacological treatment, in particular statins and anticoagulants, may improve fibrin structure and function. Prospective studies have suggested that prothrombotic fibrin clot phenotype can predict cardiovascular events in short- and long-term follow-ups. Mutations and splice variants of the fibrinogen molecule that have been proved to be associated with thrombophilia or increased cardiovascular risk, along with fibrinogen post-translational modifications, prothrombotic state, inflammation, platelet activation, and neutrophil extracellular traps formation, contribute also to prothrombotic fibrin clot phenotype. Moreover, about 500 clot-bound proteins have been identified within plasma fibrin clots, including fibronectin, \u03b12-antiplasmin, factor XIII, complement component C3, and histidine-rich glycoprotein. This review summarizes the current knowledge on the mechanisms underlying unfavourable fibrin clot properties and their implications in CVD and its thrombo-embolic manifestations.<\/jats:p>","DOI":"10.1093\/cvr\/cvad017","type":"journal-article","created":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T21:37:59Z","timestamp":1674164279000},"page":"94-111","source":"Crossref","is-referenced-by-count":163,"title":["Fibrin clot properties in cardiovascular disease: from basic mechanisms to clinical practice"],"prefix":"10.1093","volume":"119","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-1762-308X","authenticated-orcid":false,"given":"Micha\u0142","family":"Z\u0105bczyk","sequence":"first","affiliation":[{"name":"Thromboembolic Disorders Department, Institute of Cardiology, Jagiellonian University Medical College , 80 Pradnicka St, 31-202 Krakow , Poland"},{"name":"Krakow Center for Medical Research and Technologies, John Paul II Hospital , Krakow , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6310-5745","authenticated-orcid":false,"given":"Robert A S","family":"Ari\u00ebns","sequence":"additional","affiliation":[{"name":"Discovery and Translational Science Department, Leeds Institute of Cardiovascular and Metabolic Medicine, University of Leeds , Leeds , UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3716-1724","authenticated-orcid":false,"given":"Anetta","family":"Undas","sequence":"additional","affiliation":[{"name":"Thromboembolic Disorders Department, Institute of Cardiology, Jagiellonian University Medical College , 80 Pradnicka St, 31-202 Krakow , Poland"},{"name":"Krakow Center for Medical Research and Technologies, John Paul II Hospital , Krakow , Poland"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2023,1,20]]},"reference":[{"key":"2023072814562684700_cvad017-B1","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics-2022 update: a report from the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"key":"2023072814562684700_cvad017-B2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.jacc.2021.12.017","article-title":"Inflammation, aging, and cardiovascular disease: JACC review topic of the week","volume":"79","author":"Liberale","year":"2022","journal-title":"J Am Coll Cardiol"},{"key":"2023072814562684700_cvad017-B3","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1111\/jth.12545","article-title":"The Northwick Park Heart Study: evidence from the laboratory","volume":"12","author":"ten Cate","year":"2014","journal-title":"J Thromb Haemost"},{"key":"2023072814562684700_cvad017-B4","first-page":"1799","article-title":"Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis","volume":"294","author":"Fibrinogen Studies Collaboration","year":"2005","journal-title":"JAMA"},{"key":"2023072814562684700_cvad017-B5","doi-asserted-by":"crossref","first-page":"e0216222","DOI":"10.1371\/journal.pone.0216222","article-title":"Mendelian randomization evaluation of causal effects of fibrinogen on incident coronary heart disease","volume":"14","author":"Ward-Caviness","year":"2019","journal-title":"PLoS One"},{"key":"2023072814562684700_cvad017-B6","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/978-3-030-58971-4_15","article-title":"Fibrinogen and fibrin","volume":"96","author":"Litvinov","year":"2021","journal-title":"Subcell Biochem"},{"key":"2023072814562684700_cvad017-B7","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1126\/science.1127317","article-title":"Fibrin fibers have extraordinary extensibility and elasticity","volume":"313","author":"Liu","year":"2006","journal-title":"Science"},{"key":"2023072814562684700_cvad017-B8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.cca.2019.01.013","article-title":"Plasminogen activator inhibitor 1 in acute coronary syndromes","volume":"491","author":"Pavlov","year":"2019","journal-title":"Clin Chim Acta"},{"key":"2023072814562684700_cvad017-B9","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12959-018-0166-4","article-title":"Association between plasminogen activator inhibitor-1 and cardiovascular events: a systematic review and meta-analysis","volume":"16","author":"Jung","year":"2018","journal-title":"Thromb J"},{"key":"2023072814562684700_cvad017-B10","doi-asserted-by":"crossref","first-page":"4652","DOI":"10.1074\/jbc.M111.317719","article-title":"A high affinity interaction of plasminogen with fibrin is not essential for efficient activation by tissue-type plasminogen activator","volume":"287","author":"Kim","year":"2012","journal-title":"J Biol Chem"},{"key":"2023072814562684700_cvad017-B11","doi-asserted-by":"crossref","first-page":"12537","DOI":"10.3390\/ijms222212537","article-title":"Fibrinogen and antifibrinolytic proteins: interactions and future therapeutics","volume":"22","author":"Pechlivani","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2023072814562684700_cvad017-B12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.3390\/ijms23010193","article-title":"Fibrinogen and atherosclerotic cardiovascular diseases\u2014review of the literature and clinical studies","volume":"23","author":"Surma","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2023072814562684700_cvad017-B13","doi-asserted-by":"crossref","first-page":"e88","DOI":"10.1161\/ATVBAHA.111.230631","article-title":"Fibrin clot structure and function: a role in the pathophysiology of arterial and venous thromboembolic diseases","volume":"31","author":"Undas","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023072814562684700_cvad017-B14","doi-asserted-by":"crossref","first-page":"873","DOI":"10.20452\/pamw.4165","article-title":"Plasma fibrin clot structure and thromboembolism: clinical implications","volume":"127","author":"Z\u0105bczyk","year":"2017","journal-title":"Pol Arch Intern Med"},{"key":"2023072814562684700_cvad017-B15","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/jth.15531","article-title":"Why fibrin biomechanical properties matter for hemostasis and thrombosis","volume":"20","author":"Feller","year":"2022","journal-title":"J Thromb Haemost"},{"key":"2023072814562684700_cvad017-B16","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.1093\/eurheartj\/ehy013","article-title":"Fibrin clot properties independently predict adverse clinical outcome following acute coronary syndrome: a PLATO substudy","volume":"39","author":"Sumaya","year":"2018","journal-title":"Eur Heart J"},{"key":"2023072814562684700_cvad017-B17","first-page":"16113","article-title":"Fibrin clot properties in coronary artery disease: new determinants and prognostic markers","volume":"131","author":"Larsen","year":"2021","journal-title":"Pol Arch Intern Med"},{"key":"2023072814562684700_cvad017-B18","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1055\/s-0036-1579636","article-title":"How to assess fibrinogen levels and fibrin clot properties in clinical practice?","volume":"42","author":"Undas","year":"2016","journal-title":"Semin Thromb Hemost"},{"key":"2023072814562684700_cvad017-B19","doi-asserted-by":"crossref","first-page":"4721","DOI":"10.1182\/blood.V92.12.4721","article-title":"Structural studies of fibrinolysis by electron microscopy","volume":"92","author":"Veklich","year":"1998","journal-title":"Blood"},{"key":"2023072814562684700_cvad017-B20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/jth.12455","article-title":"The effect of blood coagulation factor XIII on fibrin clot structure and fibrinolysis","volume":"12","author":"Hethershaw","year":"2014","journal-title":"J Thromb Haemost"},{"key":"2023072814562684700_cvad017-B21","doi-asserted-by":"crossref","first-page":"1354","DOI":"10.1161\/01.ATV.20.5.1354","article-title":"Influence of fibrin network conformation and fibrin fiber diameter on fibrinolysis speed: dynamic and structural approaches by confocal microscopy","volume":"20","author":"Collet","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023072814562684700_cvad017-B22","doi-asserted-by":"crossref","first-page":"9843","DOI":"10.1021\/bi000045c","article-title":"Decreased lateral aggregation of a variant recombinant fibrinogen provides insight into the polymerization mechanism","volume":"39","author":"Mullin","year":"2000","journal-title":"Biochemistry"},{"key":"2023072814562684700_cvad017-B23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2020.10.014","article-title":"Determinants of plasma fibrin clot lysis measured using three different assays in healthy subjects","volume":"197","author":"Siudut","year":"2021","journal-title":"Thromb Res"},{"key":"2023072814562684700_cvad017-B24","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1111\/jth.14002","article-title":". An international study on the feasibility of a standardized combined plasma clot turbidity and lysis assay: communication from the SSC of the ISTH","volume":"16","author":"Pieters","year":"2018","journal-title":"J Thromb Haemost"},{"key":"2023072814562684700_cvad017-B25","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1111\/j.1538-7836.2012.04883.x","article-title":". An international study on the standardization of fibrin clot permeability measurement: methodological considerations and implications for healthy control values","volume":"10","author":"Pieters","year":"2012","journal-title":"J Thromb Haemost"},{"key":"2023072814562684700_cvad017-B26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1055\/s-0040-1718888","article-title":"The clotting trigger is an important determinant for the coagulation pathway in vivo or in vitro-inference from data review","volume":"47","author":"He","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"2023072814562684700_cvad017-B27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1055\/a-1492-6143","article-title":"Lifestyle influences changes in fibrin clot properties over a 10-year period on a population level","volume":"122","author":"Swanepoel","year":"2022","journal-title":"Thromb Haemost"},{"key":"2023072814562684700_cvad017-B28","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1002\/ajh.23599","article-title":"TEG And ROTEM: technology and clinical applications","volume":"89","author":"Whiting","year":"2014","journal-title":"Am J Hematol"},{"key":"2023072814562684700_cvad017-B29","doi-asserted-by":"crossref","first-page":"667","DOI":"10.33963\/KP.15493","article-title":"New methodological approaches for assessing thrombus formation in cardiovascular disease","volume":"78","author":"Hosokawa","year":"2020","journal-title":"Kardiol Pol"},{"key":"2023072814562684700_cvad017-B30","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/MOH.0b013e3280dce58c","article-title":"Fibrinogen and fibrin: scaffold proteins in hemostasis","volume":"14","author":"Lord","year":"2007","journal-title":"Curr Opin Hematol"},{"key":"2023072814562684700_cvad017-B31","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.thromres.2011.11.040","article-title":"Factor XIII, clot structure, thrombosis","volume":"129","author":"Bagoly","year":"2012","journal-title":"Thromb Res"},{"key":"2023072814562684700_cvad017-B32","doi-asserted-by":"crossref","first-page":"17301","DOI":"10.1038\/s41598-018-35034-x","article-title":"Differences in plasma fibrin clot composition in patients with thrombotic antiphospholipid syndrome compared with venous thromboembolism","volume":"8","author":"Stachowicz","year":"2018","journal-title":"Sci Rep"},{"key":"2023072814562684700_cvad017-B33","doi-asserted-by":"crossref","first-page":"103946","DOI":"10.1016\/j.jprot.2020.103946","article-title":"Plasma fibrin clot proteomics in patients with acute pulmonary embolism: association with clot properties","volume":"229","author":"Bryk","year":"2020","journal-title":"J Proteomics"},{"key":"2023072814562684700_cvad017-B34","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1046\/j.1538-7836.2003.00298.x","article-title":"What is all that thrombin for?","volume":"1","author":"Mann","year":"2003","journal-title":"J Thromb Haemost"},{"key":"2023072814562684700_cvad017-B35","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1182\/blood-2002-08-2527","article-title":"Elevated prothrombin results in clots with an altered fiber structure: a possible mechanism of the increased thrombotic risk","volume":"101","author":"Wolberg","year":"2003","journal-title":"Blood"},{"key":"2023072814562684700_cvad017-B36","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.thromres.2005.02.007","article-title":"Marked increase of fibrin gel permeability with very low dose ASA treatment","volume":"116","author":"Antovic","year":"2005","journal-title":"Thromb Res"},{"key":"2023072814562684700_cvad017-B37","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1161\/ATVBAHA.109.183707","article-title":"Effects of aspirin on clot structure and fibrinolysis using a novel in vitro cellular system","volume":"29","author":"Ajjan","year":"2009","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023072814562684700_cvad017-B38","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1111\/j.1538-7836.2006.01882.x","article-title":"Statins, fenofibrate, and quinapril increase clot permeability and enhance fibrinolysis in patients with coronary artery disease","volume":"4","author":"Undas","year":"2006","journal-title":"J Thromb Haemost"},{"key":"2023072814562684700_cvad017-B39","doi-asserted-by":"crossref","first-page":"354","DOI":"10.20452\/pamw.707","article-title":"Simvastatin increases clot permeability and susceptibility to lysis in patients with LDL cholesterol below 3.4 mmol\/l","volume":"119","author":"Undas","year":"2009","journal-title":"Pol Arch Med Wewn"},{"key":"2023072814562684700_cvad017-B40","doi-asserted-by":"crossref","first-page":"1180","DOI":"10.1160\/TH11-12-0851","article-title":"Effects of atorvastatin on plasma fibrin clot properties in apparently healthy individuals and patients with previous venous thromboembolism","volume":"107","author":"Zolcinski","year":"2012","journal-title":"Thromb Haemost"},{"key":"2023072814562684700_cvad017-B41","doi-asserted-by":"crossref","first-page":"106977","DOI":"10.1016\/j.vph.2022.106977","article-title":"Intensive low-density lipoprotein cholesterol lowering improves fibrin clot properties: association with lipoproteins and C-reactive protein","volume":"144","author":"Siudut","year":"2022","journal-title":"Vascul Pharmacol"},{"key":"2023072814562684700_cvad017-B42","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.thromres.2011.08.022","article-title":"Plasma fibrin clot properties in arterial hypertension and their modification by antihypertensive medication","volume":"130","author":"Rajzer","year":"2012","journal-title":"Thromb Res"},{"key":"2023072814562684700_cvad017-B43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.2337\/diabetes.51.1.189","article-title":"The effect of dimethylbiguanide on thrombin activity, FXIII activation, fibrin polymerization, and fibrin clot formation","volume":"51","author":"Standeven","year":"2002","journal-title":"Diabetes"},{"key":"2023072814562684700_cvad017-B44","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1046\/j.1538-7836.2003.00301.x","article-title":"Increased plasma fibrin gel porosity in patients with type I diabetes during continuous subcutaneous insulin infusion","volume":"1","author":"J\u00f6rneskog","year":"2003","journal-title":"J Thromb Haemost"},{"key":"2023072814562684700_cvad017-B45","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1161\/01.ATV.0000219688.43572.75","article-title":"Plasma homocysteine affects fibrin clot permeability and resistance to lysis in human subjects","volume":"26","author":"Undas","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023072814562684700_cvad017-B46","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1161\/ATVBAHA.111.228593","article-title":"Reduced thrombin formation and altered fibrin clot properties induced by polyunsaturated omega-3 fatty acids on top of dual antiplatelet therapy in patients undergoing percutaneous coronary intervention (OMEGA-PCI clot)","volume":"31","author":"Gajos","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023072814562684700_cvad017-B47","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1111\/j.1538-7836.2010.03739.x","article-title":"Dabigatran enhances clot susceptibility to fibrinolysis by mechanisms dependent on and independent of thrombin-activatable fibrinolysis inhibitor","volume":"8","author":"Ammollo","year":"2010","journal-title":"J Thromb Haemost"},{"key":"2023072814562684700_cvad017-B48","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1111\/j.1365-2141.2010.08546.x","article-title":"Effects on fibrin network porosity of anticoagulants with different modes of action and reversal by activated coagulation factor concentrate","volume":"152","author":"Blomb\u00e4ck","year":"2011","journal-title":"Br J Haematol"},{"key":"2023072814562684700_cvad017-B49","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1016\/j.thromres.2015.08.007","article-title":"Vitamin K antagonists favourably modulate fibrin clot properties in patients with atrial fibrillation as early as after 3days of treatment: relation to coagulation factors and thrombin generation","volume":"136","author":"Z\u0105bczyk","year":"2015","journal-title":"Thromb Res"},{"key":"2023072814562684700_cvad017-B50","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1160\/TH17-01-0060","article-title":"Plasma fibrin clot properties in the G20210A prothrombin mutation carriers following venous thromboembolism: the effect of rivaroxaban","volume":"117","author":"Janion-Sadowska","year":"2017","journal-title":"Thromb Haemost"},{"key":"2023072814562684700_cvad017-B51","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1111\/jth.14281","article-title":"Rivaroxaban and apixaban induce clotting factor Xa fibrinolytic activity","volume":"16","author":"Carter","year":"2018","journal-title":"J Thromb Haemost"},{"key":"2023072814562684700_cvad017-B52","doi-asserted-by":"crossref","first-page":"106783","DOI":"10.1016\/j.vph.2020.106783","article-title":"Effect of enoxaparin on plasma fibrin clot properties and fibrin structure in patients with acute pulmonary embolism","volume":"133\u2013134","author":"Z\u0105bczyk","year":"2020","journal-title":"Vascul Pharmacol"},{"key":"2023072814562684700_cvad017-B53","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1002\/rth2.12443","article-title":"Effect of anticoagulants on fibrin clot structure: a comparison between vitamin K antagonists and factor Xa inhibitors","volume":"4","author":"Gauer","year":"2020","journal-title":"Res Pract Thromb Haemost"},{"key":"2023072814562684700_cvad017-B54","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.atherosclerosis.2014.10.020","article-title":"Coronary thrombus composition: links with inflammation, platelet and endothelial markers","volume":"237","author":"Sadowski","year":"2014","journal-title":"Atherosclerosis"},{"key":"2023072814562684700_cvad017-B55","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s12933-018-0789-6","article-title":"Polyhedrocytes in blood clots of type 2 diabetic patients with high cardiovascular risk: association with glycemia, oxidative stress and platelet activation","volume":"17","author":"Gajos","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"2023072814562684700_cvad017-B56","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1161\/hh0402.105095","article-title":"A structural and dynamic investigation of the facilitating effect of glycoprotein IIb\/IIIa inhibitors in dissolving platelet-rich clots","volume":"90","author":"Collet","year":"2002","journal-title":"Circ Res"},{"key":"2023072814562684700_cvad017-B57","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1097\/00001721-199512000-00004","article-title":"The effect of acetylsalicylic acid on fibrin gel lysis by tissue plasminogen activator","volume":"6","author":"Williams","year":"1995","journal-title":"Blood Coagul Fibrinolysis"},{"key":"2023072814562684700_cvad017-B58","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1093\/oxfordjournals.eurheartj.a015070","article-title":"Acetylsalicylic acid may protect the patient by increasing fibrin gel porosity. Is withdrawing of treatment harmful to the patient?","volume":"17","author":"Fatah","year":"1996","journal-title":"Eur Heart J"},{"key":"2023072814562684700_cvad017-B59","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1002\/rth2.12162","article-title":"Polyphosphate in thrombosis, hemostasis, and inflammation","volume":"3","author":"Baker","year":"2019","journal-title":"Res Pract Thromb Haemost"},{"key":"2023072814562684700_cvad017-B60","doi-asserted-by":"crossref","first-page":"3980","DOI":"10.1182\/blood-2009-11-254029","article-title":"Polyphosphate modifies the fibrin network and down-regulates fibrinolysis by attenuating binding of tPA and plasminogen to fibrin","volume":"115","author":"Mutch","year":"2010","journal-title":"Blood"},{"key":"2023072814562684700_cvad017-B61","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1182\/blood-2013-08-523860","article-title":"Clot contraction: compression of erythrocytes into tightly packed polyhedra and redistribution of platelets and fibrin","volume":"123","author":"Cines","year":"2014","journal-title":"Blood"},{"key":"2023072814562684700_cvad017-B62","first-page":"515","article-title":"Platelet glycoprotein IIb\/IIIa receptor inhibitor tirofiban in acute ischemic stroke","volume":"79","author":"Yang","year":"2019","journal-title":"Drugs"},{"key":"2023072814562684700_cvad017-B63","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1055\/s-0037-1613104","article-title":"Tirofiban blocks platelet adhesion to fibrin with minimal perturbation of GpIIb\/IIIa structure","volume":"87","author":"Hantgan","year":"2002","journal-title":"Thromb Haemost"},{"key":"2023072814562684700_cvad017-B64","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1160\/TH13-11-0980","article-title":"Altered fibrin clot structure\/function in patients with antiphospholipid syndrome: association with thrombotic manifestation","volume":"112","author":"Celi\u0144ska-Lowenhoff","year":"2014","journal-title":"Thromb Haemost"},{"key":"2023072814562684700_cvad017-B65","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/j.thromres.2014.02.023","article-title":"Studies of fibrin formation and fibrinolytic function in patients with the antiphospholipid syndrome","volume":"133","author":"Vikerfors","year":"2014","journal-title":"Thromb Res"},{"key":"2023072814562684700_cvad017-B66","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1160\/TH09-02-0118","article-title":"Fibrin clot properties are altered in patients with chronic obstructive pulmonary disease. Beneficial effects of simvastatin treatment","volume":"102","author":"Undas","year":"2009","journal-title":"Thromb Haemost"},{"key":"2023072814562684700_cvad017-B67","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.1016\/j.thromres.2010.04.007","article-title":"Unfavorably altered fibrin clot properties in patients with active rheumatoid arthritis","volume":"126","author":"Kwasny-Krochin","year":"2010","journal-title":"Thromb Res"},{"key":"2023072814562684700_cvad017-B68","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s00296-011-1805-2","article-title":"Scanning electron microscopy of fibrin networks in rheumatoid arthritis: a qualitative analysis","volume":"32","author":"Pretorius","year":"2012","journal-title":"Rheumatol Int"},{"key":"2023072814562684700_cvad017-B69","doi-asserted-by":"crossref","first-page":"577523","DOI":"10.3389\/fimmu.2020.577523","article-title":"Detection of citrullinated fibrin in plasma clots of rheumatoid arthritis patients and its relation to altered structural clot properties, disease-related inflammation and prothrombotic tendency","volume":"11","author":"Bezuidenhout","year":"2020","journal-title":"Front Immunol"},{"key":"2023072814562684700_cvad017-B70","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/j.1538-7836.2006.01903.x","article-title":"Lipoprotein(a) as a modifier of fibrin clot permeability and susceptibility to lysis","volume":"4","author":"Undas","year":"2006","journal-title":"J Thromb Haemost"},{"key":"2023072814562684700_cvad017-B71","doi-asserted-by":"crossref","first-page":"9540","DOI":"10.3390\/ijms22179540","article-title":"Fibrin network formation and lysis in septic shock patients","volume":"22","author":"Larsen","year":"2021","journal-title":"Int J Mol Sci"},{"key":"2023072814562684700_cvad017-B72","doi-asserted-by":"crossref","first-page":"e557","DOI":"10.1097\/CCM.0000000000005465","article-title":"Aberrant fibrin clot structure visualized ex vivo in critically ill patients with severe acute respiratory syndrome coronavirus 2 infection","volume":"50","author":"Brubaker","year":"2022","journal-title":"Crit Care Med"},{"key":"2023072814562684700_cvad017-B73","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1182\/bloodadvances.2021004816","article-title":"Altered fibrin clot structure and dysregulated fibrinolysis contribute to thrombosis risk in severe COVID-19","volume":"6","author":"Wygrecka","year":"2022","journal-title":"Blood Adv"},{"key":"2023072814562684700_cvad017-B74","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1160\/TH11-11-0822","article-title":"Stimulated in vivo synthesis of plasminogen activator inhibitor-1 in human adipose tissue","volume":"108","author":"Ekstr\u00f6m","year":"2012","journal-title":"Thromb Haemost"},{"key":"2023072814562684700_cvad017-B75","doi-asserted-by":"crossref","first-page":"6946","DOI":"10.1074\/jbc.M112.404301","article-title":"Mechanical stability and fibrinolytic resistance of clots containing fibrin, DNA, and histones","volume":"288","author":"Longstaff","year":"2013","journal-title":"J Biol Chem"},{"key":"2023072814562684700_cvad017-B76","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1160\/TH14-08-0669","article-title":"DNA, histones and neutrophil extracellular traps exert anti-fibrinolytic effects in a plasma environment","volume":"113","author":"Varj\u00fa","year":"2015","journal-title":"Thromb Haemost"},{"key":"2023072814562684700_cvad017-B77","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.thromres.2021.11.011","article-title":"Fibrin to von Willebrand factor ratio in arterial thrombi is associated with plasma levels of inflammatory biomarkers and local abundance of extracellular DNA","volume":"209","author":"T\u00f3th","year":"2022","journal-title":"Thromb Res"},{"key":"2023072814562684700_cvad017-B78","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1160\/TH12-06-0425","article-title":"Neutrophils, neutrophil extracellular traps and interleukin-17 associate with the organisation of thrombi in acute myocardial infarction","volume":"109","author":"de Boer","year":"2013","journal-title":"Thromb Haemost"},{"key":"2023072814562684700_cvad017-B79","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1161\/STROKEAHA.117.019896","article-title":"Thrombus neutrophil extracellular traps content impair tPA-induced thrombolysis in acute ischemic stroke","volume":"49","author":"Ducroux","year":"2018","journal-title":"Stroke"},{"key":"2023072814562684700_cvad017-B80","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.thromres.2019.01.006","article-title":"Neutrophil extracellular traps in thrombi retrieved during interventional treatment of ischemic arterial diseases","volume":"175","author":"Farkas","year":"2019","journal-title":"Thromb Res"},{"key":"2023072814562684700_cvad017-B81","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.thromres.2022.02.025","article-title":"Markers of NET formation and stroke risk in patients with atrial fibrillation: association with a prothrombotic state","volume":"213","author":"Mo\u0142ek","year":"2022","journal-title":"Thromb Res"},{"key":"2023072814562684700_cvad017-B82","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12933-019-0850-0","article-title":"Predictors of neutrophil extracellular traps markers in type 2 diabetes mellitus: associations with a prothrombotic state and hypofibrinolysis","volume":"18","author":"Bryk","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"2023072814562684700_cvad017-B83","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1111\/jth.14216","article-title":". Diagnosis and classification of congenital fibrinogen disorders: communication from the SSC of the ISTH","volume":"16","author":"Casini","year":"2018","journal-title":"J Thromb Haemost"},{"key":"2023072814562684700_cvad017-B84","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1055\/s-0037-1614006","article-title":"Fibrinogen Caracas V, an abnormal fibrinogen with an Aalpha 532 Ser\u2013&gt;Cys substitution associated with thrombosis","volume":"84","author":"Marchi","year":"2000","journal-title":"Thromb Haemost"},{"key":"2023072814562684700_cvad017-B85","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1172\/JCI115841","article-title":"Molecular basis of fibrinogen Naples associated with defective thrombin binding and thrombophilia. Homozygous substitution of B beta 68 Ala\u2014Thr","volume":"90","author":"Koopman","year":"1992","journal-title":"J Clin Invest"},{"key":"2023072814562684700_cvad017-B86","doi-asserted-by":"crossref","first-page":"2462","DOI":"10.1182\/blood.V82.8.2462.2462","article-title":"Dusart syndrome: a new concept of the relationship between fibrin clot architecture and fibrin clot degradability: hypofibrinolysis related to an abnormal clot structure","volume":"82","author":"Collet","year":"1993","journal-title":"Blood"},{"key":"2023072814562684700_cvad017-B87","first-page":"934","article-title":"Fibrinogen \u0141\u00f3d\u017a: a new cause of dysfibrinogenemia associated with recurrent thromboembolic arterial events","volume":"129","author":"Treli\u0144ski","year":"2019","journal-title":"Pol Arch Intern Med"},{"issue":"Suppl. 2","key":"2023072814562684700_cvad017-B88","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1016\/S0049-3848(16)30358-9","article-title":"Novel mechanisms that regulate clot structure\/function","volume":"141","author":"Ari\u00ebns","year":"2016","journal-title":"Thromb Res"},{"key":"2023072814562684700_cvad017-B89","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1538-7836.2012.04717.x","article-title":"Evidence that fibrinogen \u03b3\u2019 directly interferes with protofibril growth: implications for fibrin structure and clot stiffness","volume":"10","author":"Allan","year":"2012","journal-title":"J Thromb Haemost"},{"key":"2023072814562684700_cvad017-B90","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1182\/blood-2015-06-652214","article-title":"Thrombin and fibrinogen \u03b3\u2019 impact clot structure by marked effects on intrafibrillar structure and protofibril packing","volume":"127","author":"Domingues","year":"2016","journal-title":"Blood"},{"key":"2023072814562684700_cvad017-B91","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1055\/s-0037-1613148","article-title":"Association of gammaA\/gamma\u2019 fibrinogen levels and coronary artery disease","volume":"88","author":"Lovely","year":"2002","journal-title":"Thromb Haemost"},{"key":"2023072814562684700_cvad017-B92","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1111\/j.1538-7836.2007.02406.x","article-title":"Elevated plasma fibrinogen gamma\u2019 concentration is associated with myocardial infarction: effects of variation in fibrinogen genes and environmental factors","volume":"5","author":"Mannila","year":"2007","journal-title":"J Thromb Haemost"},{"key":"2023072814562684700_cvad017-B93","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1161\/STROKEAHA.107.495499","article-title":"Fibrinogen gamma\u2019 in ischemic stroke: a case-control study","volume":"39","author":"Cheung","year":"2008","journal-title":"Stroke"},{"key":"2023072814562684700_cvad017-B94","doi-asserted-by":"crossref","first-page":"4603","DOI":"10.1182\/blood-2009-08-236240","article-title":"Elevated fibrinogen gamma\u2019 ratio is associated with cardiovascular diseases and acute phase reaction but not with clinical outcome","volume":"114","author":"Cheung","year":"2009","journal-title":"Blood"},{"key":"2023072814562684700_cvad017-B95","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.1161\/ATVBAHA.111.232710","article-title":"Assessment of genetic determinants of the association of \u03b3\u2019 fibrinogen in relation to cardiovascular disease","volume":"31","author":"Lovely","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023072814562684700_cvad017-B96","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1182\/blood-2012-12-471482","article-title":"Evidence that fibrinogen \u03b3\u2019 regulates plasma clot structure and lysis and relationship to cardiovascular risk factors in black Africans","volume":"121","author":"Pieters","year":"2013","journal-title":"Blood"},{"key":"2023072814562684700_cvad017-B97","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1161\/ATVBAHA.119.313626","article-title":"Effects of post-translational modifications of fibrinogen on clot formation, clot structure, and fibrinolysis: a systematic review","volume":"40","author":"de Vries","year":"2020","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023072814562684700_cvad017-B98","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1161\/CIRCULATIONAHA.115.017738","article-title":"Neutrophil activation promotes fibrinogen oxidation and thrombus formation in Beh\u00e7et disease","volume":"133","author":"Becatti","year":"2016","journal-title":"Circulation"},{"key":"2023072814562684700_cvad017-B99","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.atherosclerosis.2007.05.028","article-title":"Reduced clot permeability and susceptibility to lysis in patients with acute coronary syndrome: effects of inflammation and oxidative stress","volume":"196","author":"Undas","year":"2008","journal-title":"Atherosclerosis"},{"key":"2023072814562684700_cvad017-B100","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1161\/ATVBAHA.114.303785","article-title":"Oxidative modification of fibrinogen is associated with altered function and structure in the subacute phase of myocardial infarction","volume":"34","author":"Becatti","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023072814562684700_cvad017-B101","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.freeradbiomed.2016.04.023","article-title":"Post-translational oxidative modification of fibrinogen is associated with coagulopathy after traumatic injury","volume":"96","author":"White","year":"2016","journal-title":"Free Radic Biol Med"},{"key":"2023072814562684700_cvad017-B102","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3390\/jcm11010246","article-title":"8-Isoprostanes and asymmetric dimethylarginine as predictors of mortality in patients following coronary bypass surgery: a long-term follow-up study","volume":"11","author":"Go\u0142\u0105b","year":"2022","journal-title":"J Clin Med"},{"key":"2023072814562684700_cvad017-B103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2022.07.034","article-title":"Elevated 8-isoprostane concentration is associated with thromboembolic events in patients with atrial fibrillation","volume":"365","author":"Mo\u0142ek","year":"2022","journal-title":"Int J Cardiol"},{"key":"2023072814562684700_cvad017-B104","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.bbrc.2022.06.063","article-title":"Mass-spectrometric identification of oxidative modifications in plasma-purified plasminogen: association with hypofibrinolysis in patients with acute pulmonary embolism","volume":"621","author":"Bryk-Wi\u0105zania","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"2023072814562684700_cvad017-B105","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1160\/TH06-07-0390","article-title":"The effect of glycaemic control on fibrin network structure of type 2 diabetic subjects","volume":"96","author":"Pieters","year":"2006","journal-title":"Thromb Haemost"},{"key":"2023072814562684700_cvad017-B106","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1007\/s00125-005-1742-2","article-title":"The influence of type 2 diabetes on fibrin structure and function","volume":"48","author":"Dunn","year":"2005","journal-title":"Diabetologia"},{"key":"2023072814562684700_cvad017-B107","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1160\/TH07-11-0699","article-title":"Glycaemic control improves fibrin network characteristics in type 2 diabetes\u2014a purified fibrinogen model","volume":"99","author":"Pieters","year":"2008","journal-title":"Thromb Haemost"},{"key":"2023072814562684700_cvad017-B108","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1152\/physrev.00003.2018","article-title":"Homocysteine modification in protein structure\/function and human disease","volume":"99","author":"Jakubowski","year":"2019","journal-title":"Physiol Rev"},{"key":"2023072814562684700_cvad017-B109","doi-asserted-by":"crossref","first-page":"e68761","DOI":"10.7554\/eLife.68761","article-title":"Fibrinogen \u03b1C-subregions critically contribute blood clot fibre growth, mechanical stability, and resistance to fibrinolysis","volume":"10","author":"McPherson","year":"2021","journal-title":"Elife"},{"key":"2023072814562684700_cvad017-B110","doi-asserted-by":"crossref","first-page":"4015","DOI":"10.1182\/bloodadvances.2022006977","article-title":"Fibrin protofibril packing and clot stability are enhanced by extended knob-hole interactions and catch-slip bonds","volume":"6","author":"Asquith","year":"2022","journal-title":"Blood Adv"},{"key":"2023072814562684700_cvad017-B111","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2103226118","article-title":"Elimination of fibrin \u03b3-chain cross-linking by FXIIIa increases pulmonary embolism arising from murine inferior vena cava thrombi","volume":"118","author":"Duval","year":"2021","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2023072814562684700_cvad017-B112","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2141.2008.07569.x","article-title":"Reduced plasma fibrinolytic capacity as a potential risk factor for a first myocardial infarction in young men","volume":"145","author":"Meltzer","year":"2009","journal-title":"Br J Haematol"},{"key":"2023072814562684700_cvad017-B113","doi-asserted-by":"crossref","first-page":"e48881","DOI":"10.1371\/journal.pone.0048881","article-title":"Plasma clot lysis time and its association with cardiovascular risk factors in black Africans","volume":"7","author":"de Lange","year":"2012","journal-title":"PLoS One"},{"key":"2023072814562684700_cvad017-B114","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1055\/s-0038-1650618","article-title":"Proneness to formation of tight and rigid fibrin gel structures in men with myocardial infarction at a young age","volume":"76","author":"Fatah","year":"1996","journal-title":"Thromb Haemost"},{"key":"2023072814562684700_cvad017-B115","doi-asserted-by":"crossref","first-page":"2783","DOI":"10.1161\/ATVBAHA.107.153221","article-title":"Heritability of clot formation, morphology, and lysis: the EuroCLOT study","volume":"27","author":"Carter","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023072814562684700_cvad017-B116","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1016\/j.thromres.2015.05.033","article-title":"The association of clot lysis time with total obesity is partly independent from the association of PAI-1 with central obesity in African adults","volume":"136","author":"Eksteen","year":"2015","journal-title":"Thromb Res"},{"key":"2023072814562684700_cvad017-B117","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1161\/01.CIR.0000033221.73082.06","article-title":"Altered fibrin clot structure in the healthy relatives of patients with premature coronary artery disease","volume":"106","author":"Mills","year":"2002","journal-title":"Circulation"},{"key":"2023072814562684700_cvad017-B118","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1160\/TH13-07-0566","article-title":"Prolonged duration of type 2 diabetes is associated with increased thrombin generation, prothrombotic fibrin clot phenotype and impaired fibrinolysis","volume":"111","author":"Konieczynska","year":"2014","journal-title":"Thromb Haemost"},{"key":"2023072814562684700_cvad017-B119","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1160\/TH17-04-0259","article-title":"Interplay between elevated cellular fibronectin and plasma fibrin clot properties in type 2 diabetes","volume":"117","author":"Konieczy\u0144ska","year":"2017","journal-title":"Thromb Haemost"},{"key":"2023072814562684700_cvad017-B120","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1160\/TH09-03-0187","article-title":"Effect of cigarette smoking on plasma fibrin clot permeability and susceptibility to lysis","volume":"102","author":"Undas","year":"2009","journal-title":"Thromb Haemost"},{"key":"2023072814562684700_cvad017-B121","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1161\/ATVBAHA.109.195024","article-title":"Effects of cigarette smoke exposure on clot dynamics and fibrin structure: an ex vivo investigation","volume":"30","author":"Barua","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023072814562684700_cvad017-B122","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1055\/s-0039-1698460","article-title":"Interpretation and validation of maximum absorbance data obtained from turbidimetry analysis of plasma clots","volume":"120","author":"Pieters","year":"2020","journal-title":"Thromb Haemost"},{"key":"2023072814562684700_cvad017-B123","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1160\/TH10-01-0048","article-title":"The effect of ethanol and its metabolism on fibrinolysis","volume":"104","author":"Pieters","year":"2010","journal-title":"Thromb Haemost"},{"key":"2023072814562684700_cvad017-B124","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.atherosclerosis.2022.01.011","article-title":"Apolipoproteins and lipoprotein(a) as factors modulating fibrin clot properties in patients with severe aortic stenosis","volume":"344","author":"Siudut","year":"2022","journal-title":"Atherosclerosis"},{"key":"2023072814562684700_cvad017-B125","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1111\/j.1365-2141.2008.07568.x","article-title":"Hypofibrinolysis is a risk factor for arterial thrombosis at young age","volume":"145","author":"Guimar\u00e3es","year":"2009","journal-title":"Br J Haematol"},{"key":"2023072814562684700_cvad017-B126","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/nm0796-800","article-title":"Enhanced expression of PAI-1 in visceral fat: possible contributor to vascular disease in obesity","volume":"2","author":"Shimomura","year":"1996","journal-title":"Nat Med"},{"key":"2023072814562684700_cvad017-B127","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/s12933-021-01372-w","article-title":"Hypofibrinolysis in type 2 diabetes and its clinical implications: from mechanisms to pharmacological modulation","volume":"20","author":"Bryk-Wi\u0105zania","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"2023072814562684700_cvad017-B128","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00125-006-0197-4","article-title":"Molecular mechanisms involved in the resistance of fibrin to clot lysis by plasmin in subjects with type 2 diabetes mellitus","volume":"49","author":"Dunn","year":"2006","journal-title":"Diabetologia"},{"key":"2023072814562684700_cvad017-B129","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00125-011-2301-7","article-title":"A novel mechanism for hypofibrinolysis in diabetes: the role of complement C3","volume":"55","author":"Hess","year":"2012","journal-title":"Diabetologia"},{"issue":"Suppl. 1","key":"2023072814562684700_cvad017-B130","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S0140-6736(15)60372-5","article-title":"Inhibition of complement C3 and fibrinogen interaction: a potential novel therapeutic target to reduce cardiovascular disease in diabetes","volume":"385","author":"King","year":"2015","journal-title":"Lancet"},{"key":"2023072814562684700_cvad017-B131","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12933-021-01230-9","article-title":"Plasma fibrin clot properties and cardiovascular mortality in patients with type 2 diabetes: a long-term follow-up study","volume":"20","author":"Bryk","year":"2021","journal-title":"Cardiovasc Diabetol"},{"key":"2023072814562684700_cvad017-B132","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.2337\/dc18-0050","article-title":"Prolonged prothrombotic effects of antecedent hypoglycemia in individuals with type 2 diabetes","volume":"41","author":"Chow","year":"2018","journal-title":"Diabetes Care"},{"key":"2023072814562684700_cvad017-B133","doi-asserted-by":"crossref","first-page":"2567","DOI":"10.1161\/01.ATV.0000241589.52950.4c","article-title":"Altered fibrin architecture is associated with hypofibrinolysis and premature coronary atherothrombosis","volume":"26","author":"Collet","year":"2006","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023072814562684700_cvad017-B134","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1038\/s41569-018-0153-2","article-title":"Oxidized phospholipids as a unifying theory for lipoprotein(a) and cardiovascular disease","volume":"16","author":"Boffa","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"2023072814562684700_cvad017-B135","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.atherosclerosis.2022.04.009","article-title":"Beyond fibrinolysis: the confounding role of Lp(a) in thrombosis","volume":"349","author":"Boffa","year":"2022","journal-title":"Atherosclerosis"},{"key":"2023072814562684700_cvad017-B136","doi-asserted-by":"crossref","first-page":"16122","DOI":"10.20452\/pamw.16122","article-title":"How can exercise reduce cardiovascular disease risk? A primer for the clinician","volume":"131","author":"Dobrosielski","year":"2021","journal-title":"Pol Arch Intern Med"},{"key":"2023072814562684700_cvad017-B137","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.thromres.2016.05.018","article-title":"Effects of exercise intensity on clot microstructure and mechanical properties in healthy individuals","volume":"143","author":"Davies","year":"2016","journal-title":"Thromb Res"},{"key":"2023072814562684700_cvad017-B138","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1056\/NEJMra1011670","article-title":"The hemostatic system as a modulator of atherosclerosis","volume":"364","author":"Borissoff","year":"2011","journal-title":"N Engl J Med"},{"key":"2023072814562684700_cvad017-B139","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1055\/s-0040-1718923","article-title":"Fibrinolysis in acute and chronic cardiovascular disease","volume":"47","author":"Kietsiriroje","year":"2021","journal-title":"Semin Thromb Hemost"},{"key":"2023072814562684700_cvad017-B140","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1055\/s-0039-1701011","article-title":"Impaired fibrinolysis predicts adverse outcome in acute coronary syndrome patients with diabetes: a PLATO sub-study","volume":"120","author":"Sumaya","year":"2020","journal-title":"Thromb Haemost"},{"key":"2023072814562684700_cvad017-B141","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1160\/TH11-11-0760","article-title":"Impaired fibrinolytic capacity and increased fibrin formation associate with myocardial infarction","volume":"107","author":"Leander","year":"2012","journal-title":"Thromb Haemost"},{"key":"2023072814562684700_cvad017-B142","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1160\/TH14-09-0801","article-title":"Plasma fibrin clot phenotype independently affects intracoronary thrombus ultrastructure in patients with acute myocardial infarction","volume":"113","author":"Zalewski","year":"2015","journal-title":"Thromb Haemost"},{"key":"2023072814562684700_cvad017-B143","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1093\/cvr\/cvz019","article-title":"Fibrin biofilm can be detected on intracoronary thrombi aspirated from patients with acute myocardial infarction","volume":"115","author":"Z\u0105bczyk","year":"2019","journal-title":"Cardiovasc Res"},{"key":"2023072814562684700_cvad017-B144","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1172\/JCI98734","article-title":"A fibrin biofilm covers blood clots and protects from microbial invasion","volume":"128","author":"Macrae","year":"2018","journal-title":"J Clin Invest"},{"key":"2023072814562684700_cvad017-B145","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.ijcard.2014.10.004","article-title":"Polyhedrocytes in intracoronary thrombi from patients with ST-elevation myocardial infarction","volume":"179","author":"Z\u0105bczyk","year":"2015","journal-title":"Int J Cardiol"},{"key":"2023072814562684700_cvad017-B146","doi-asserted-by":"crossref","first-page":"5112","DOI":"10.1038\/s41598-020-59526-x","article-title":"The distinctive structure and composition of arterial and venous thrombi and pulmonary emboli","volume":"10","author":"Chernysh","year":"2020","journal-title":"Sci Rep"},{"key":"2023072814562684700_cvad017-B147","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1161\/ATVBAHA.116.308622","article-title":"Contraction of blood clots is impaired in acute ischemic stroke","volume":"37","author":"Tutwiler","year":"2017","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023072814562684700_cvad017-B148","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11239-018-1650-1","article-title":"Erythrocyte compression index is impaired in patients with residual vein obstruction","volume":"46","author":"Zabczyk","year":"2018","journal-title":"J Thromb Thrombolysis"},{"key":"2023072814562684700_cvad017-B149","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1160\/TH09-03-0199","article-title":"Fibrin network structure and clot mechanical properties are altered by incorporation of erythrocytes","volume":"102","author":"Gersh","year":"2009","journal-title":"Thromb Haemost"},{"key":"2023072814562684700_cvad017-B150","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.nano.2018.01.006","article-title":"Sensing adhesion forces between erythrocytes and \u03b3\u2019 fibrinogen, modulating fibrin clot architecture and function","volume":"14","author":"Guedes","year":"2018","journal-title":"Nanomedicine"},{"key":"2023072814562684700_cvad017-B151","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.thromres.2021.06.024","article-title":"Quantitative analysis of clot density, fibrin fiber radius, and protofibril packing in acute phase myocardial infarction","volume":"205","author":"Siniarski","year":"2021","journal-title":"Thromb Res"},{"key":"2023072814562684700_cvad017-B152","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1182\/blood-2003-07-2247","article-title":"Genetics of fibrin clot structure: a twin study","volume":"103","author":"Dunn","year":"2004","journal-title":"Blood"},{"key":"2023072814562684700_cvad017-B153","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.thromres.2013.03.015","article-title":"Detection of hypofibrinolysis in stable coronary artery disease using the overall haemostatic potential assay","volume":"131","author":"Reddel","year":"2013","journal-title":"Thromb Res"},{"key":"2023072814562684700_cvad017-B154","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.thromres.2018.12.020","article-title":"Sex difference in fibrin clot lysability: association with coronary plaque composition","volume":"174","author":"Ramanathan","year":"2019","journal-title":"Thromb Res"},{"key":"2023072814562684700_cvad017-B155","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1055\/s-0039-1700873","article-title":"Imbalance between fibrin clot formation and fibrinolysis predicts cardiovascular events in patients with stable coronary artery disease","volume":"120","author":"Neergaard-Petersen","year":"2020","journal-title":"Thromb Haemost"},{"key":"2023072814562684700_cvad017-B156","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1365-2141.2011.08935.x","article-title":"Clot lysis time and the risk of myocardial infarction and ischaemic stroke in young women; results from the RATIO case-control study","volume":"156","author":"Siegerink","year":"2012","journal-title":"Br J Haematol"},{"key":"2023072814562684700_cvad017-B157","doi-asserted-by":"crossref","first-page":"e13775","DOI":"10.1111\/eci.13775","article-title":"Impaired fibrin clot lysis is associated with increased mortality in patients after coronary artery bypass grafting: a long-term follow-up study","volume":"52","author":"Go\u0142\u0105b","year":"2022","journal-title":"Eur J Clin Invest"},{"key":"2023072814562684700_cvad017-B158","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1160\/th14-05-0468","article-title":"The influence of type 2 diabetes on fibrin clot properties in patients with coronary artery disease","volume":"112","author":"Neergaard-Petersen","year":"2014","journal-title":"Thromb Haemost"},{"key":"2023072814562684700_cvad017-B159","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1007\/s11239-012-0821-8","article-title":"Type 2 diabetes as a modifier of fibrin clot properties in patients with coronary artery disease","volume":"35","author":"Bochenek","year":"2013","journal-title":"J Thromb Thrombolysis"},{"key":"2023072814562684700_cvad017-B160","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1055\/s-0040-1713753","article-title":"The ABO locus is associated with increased fibrin network formation in patients with stable coronary artery disease","volume":"120","author":"Winther-Larsen","year":"2020","journal-title":"Thromb Haemost"},{"key":"2023072814562684700_cvad017-B161","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.3390\/jcm10132999","article-title":"Fibrin clot properties in atherosclerotic vascular disease: from pathophysiology to clinical outcomes","volume":"10","author":"Z\u0105bczyk","year":"2021","journal-title":"J Clin Med"},{"key":"2023072814562684700_cvad017-B162","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1136\/hrt.2010.192740","article-title":"Altered fibrin clot properties in patients with chronic heart failure and sinus rhythm: a novel prothrombotic mechanism","volume":"96","author":"Palka","year":"2010","journal-title":"Heart"},{"key":"2023072814562684700_cvad017-B163","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s11239-016-1344-5","article-title":"Laboratory assessment of anti-thrombotic therapy in heart failure, atrial fibrillation and coronary artery disease: insights using thrombelastography and a micro-titre plate assay of thrombogenesis and fibrinolysis","volume":"42","author":"Lau","year":"2016","journal-title":"J Thromb Thrombolysis"},{"key":"2023072814562684700_cvad017-B164","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.thromres.2009.11.013","article-title":"Fibrin clot properties in acute ischemic stroke: relation to neurological deficit","volume":"125","author":"Undas","year":"2010","journal-title":"Thromb Res"},{"key":"2023072814562684700_cvad017-B165","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1160\/TH16-12-0954","article-title":"Fibrin clot characteristics in acute ischaemic stroke patients treated with thrombolysis: the impact on clinical outcome","volume":"117","author":"Bembenek","year":"2017","journal-title":"Thromb Haemost"},{"key":"2023072814562684700_cvad017-B166","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1161\/STROKEAHA.120.032810","article-title":"Thrombus composition and efficacy of thrombolysis and thrombectomy in acute ischemic stroke","volume":"52","author":"Jolugbo","year":"2021","journal-title":"Stroke"},{"key":"2023072814562684700_cvad017-B167","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.thromres.2006.08.005","article-title":"Evidence of hypercoagulability and inflammation in young patients long after acute cerebral ischaemia","volume":"120","author":"Anzej","year":"2007","journal-title":"Thromb Res"},{"key":"2023072814562684700_cvad017-B168","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1161\/STROKEAHA.108.532812","article-title":"Altered fibrin clot structure\/function in patients with cryptogenic ischemic stroke","volume":"40","author":"Undas","year":"2009","journal-title":"Stroke"},{"key":"2023072814562684700_cvad017-B169","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1016\/j.jvs.2008.07.010","article-title":"Altered fibrin clot structure and function in the healthy first-degree relatives of subjects with intermittent claudication","volume":"48","author":"Bhasin","year":"2008","journal-title":"J Vasc Surg"},{"key":"2023072814562684700_cvad017-B170","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1016\/j.jvs.2008.11.028","article-title":"Regarding \u2018altered fibrin clot structure and function in individuals with intermittent claudication\u2019","volume":"49","author":"Bhasin","year":"2009","journal-title":"J Vasc Surg"},{"key":"2023072814562684700_cvad017-B171","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.atherosclerosis.2010.12.040","article-title":"Abnormal plasma fibrin clot characteristics are associated with worse clinical outcome in patients with peripheral arterial disease and thromboangiitis obliterans","volume":"215","author":"Undas","year":"2011","journal-title":"Atherosclerosis"},{"key":"2023072814562684700_cvad017-B172","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.thromres.2020.01.008","article-title":"A prothrombotic state and denser clot formation in patients following acute limb ischemia of unknown cause","volume":"187","author":"Karpi\u0144ska","year":"2020","journal-title":"Thromb Res"},{"key":"2023072814562684700_cvad017-B173","doi-asserted-by":"crossref","first-page":"608","DOI":"10.20452\/pamw.1535","article-title":"Altered fibrin clot properties in patients with premature peripheral artery disease","volume":"122","author":"Okraska-Bylica","year":"2012","journal-title":"Pol Arch Med Wewn"},{"key":"2023072814562684700_cvad017-B174","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1007\/s11239-019-01826-9","article-title":"Restenosis is associated with prothrombotic plasma fibrin clot characteristics in endovascularly treated patients with critical limb ischemia","volume":"47","author":"Nowakowski","year":"2019","journal-title":"J Thromb Thrombolysis"},{"key":"2023072814562684700_cvad017-B175","doi-asserted-by":"crossref","first-page":"243","DOI":"10.33963\/KP.15889","article-title":"Biomarkers in atrial fibrillation: a constant search for simplicity, practicality, and cost-effectiveness","volume":"79","author":"Boriani","year":"2021","journal-title":"Kardiol Pol"},{"key":"2023072814562684700_cvad017-B176","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.33963\/KP.a2021.0088","article-title":"Thromboembolism and bleeding in patients with atrial fibrillation and stage 4 chronic kidney disease: impact of biomarkers","volume":"79","author":"Matusik","year":"2021","journal-title":"Kardiol Pol"},{"key":"2023072814562684700_cvad017-B177","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.33963\/KP.a2021.0124","article-title":"Biomarkers for atrial fibrillation and chronic kidney disease: what is the evidence?","volume":"79","author":"Krittayaphong","year":"2021","journal-title":"Kardiol Pol"},{"key":"2023072814562684700_cvad017-B178","doi-asserted-by":"crossref","first-page":"105","DOI":"10.33963\/KP.15205","article-title":"Bleeding in anticoagulated patients with atrial fibrillation: practical considerations","volume":"78","author":"Undas","year":"2020","journal-title":"Kardiol Pol"},{"key":"2023072814562684700_cvad017-B179","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.thromres.2015.05.028","article-title":"Denser plasma clot formation and impaired fibrinolysis in paroxysmal and persistent atrial fibrillation while on sinus rhythm: association with thrombin generation, endothelial injury and platelet activation","volume":"136","author":"Drabik","year":"2015","journal-title":"Thromb Res"},{"key":"2023072814562684700_cvad017-B180","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.ijcard.2017.05.060","article-title":"Elevated NT-proBNP is associated with unfavorably altered plasma fibrin clot properties in atrial fibrillation","volume":"243","author":"Matusik","year":"2017","journal-title":"Int J Cardiol"},{"key":"2023072814562684700_cvad017-B181","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1161\/STROKEAHA.117.018143","article-title":"Fibrin clot permeability as a predictor of stroke and bleeding in anticoagulated patients with atrial fibrillation","volume":"48","author":"Drabik","year":"2017","journal-title":"Stroke"},{"key":"2023072814562684700_cvad017-B182","doi-asserted-by":"publisher","author":"Janion-Sadowska","DOI":"10.1161\/STROKEAHA.118.023712"},{"key":"2023072814562684700_cvad017-B183","doi-asserted-by":"crossref","first-page":"3004","DOI":"10.1161\/ATVBAHA.111.236786","article-title":"Clot architecture is altered in abdominal aortic aneurysms and correlates with aneurysm size","volume":"31","author":"Scott","year":"2011","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"2023072814562684700_cvad017-B184","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1182\/bloodadvances.2017013359","article-title":"Prognostic value of D-dimer and markers of coagulation for stratification of abdominal aortic aneurysm growth","volume":"2","author":"Sundermann","year":"2018","journal-title":"Blood Adv"},{"key":"2023072814562684700_cvad017-B185","doi-asserted-by":"crossref","first-page":"384","DOI":"10.5603\/CJ.a2018.0101","article-title":"Coexistence and management of abdominal aortic aneurysm and coronary artery disease","volume":"27","author":"Ho\u0142da","year":"2020","journal-title":"Cardiol J"},{"key":"2023072814562684700_cvad017-B186","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/jth.12122","article-title":"Impaired fibrinolysis is associated with the severity of aortic stenosis in humans","volume":"11","author":"Natorska","year":"2013","journal-title":"J Thromb Haemost"},{"key":"2023072814562684700_cvad017-B187","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s11239-018-1687-1","article-title":"Impaired fibrinolysis in degenerative mitral and aortic valve stenosis","volume":"46","author":"Mazur","year":"2018","journal-title":"J Thromb Thrombolysis"},{"key":"2023072814562684700_cvad017-B188","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.3390\/jcm9062002","article-title":"Impaired fibrinolysis in patients with isolated aortic stenosis is associated with enhanced oxidative stress","volume":"9","author":"Siudut","year":"2020","journal-title":"J Clin Med"},{"key":"2023072814562684700_cvad017-B189","doi-asserted-by":"crossref","first-page":"796","DOI":"10.33963\/KP.a2021.0005","article-title":"Patients scheduled for TAVI tend to form abnormal fibrin clots more resistant to lysis: the impact of age","volume":"79","author":"Jaworska-Wilczy\u0144ska","journal-title":"Kardiol Pol"},{"key":"2023072814562684700_cvad017-B190","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.33963\/KP.a2021.0137","article-title":"Diabetes mellitus as a risk factor for aortic stenosis: from new mechanisms to clinical implications","volume":"79","author":"Natorska","year":"2021","journal-title":"Kardiol Pol"}],"container-title":["Cardiovascular Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/cardiovascres\/advance-article-pdf\/doi\/10.1093\/cvr\/cvad017\/49089999\/cvad017.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/119\/1\/94\/50997180\/cvad017.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article-pdf\/119\/1\/94\/50997180\/cvad017.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,10,12]],"date-time":"2024-10-12T16:28:28Z","timestamp":1728750508000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/cardiovascres\/article\/119\/1\/94\/6994408"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,1]]},"references-count":190,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1,20]]},"published-print":{"date-parts":[[2023,3,17]]}},"URL":"https:\/\/doi.org\/10.1093\/cvr\/cvad017","relation":{},"ISSN":["0008-6363","1755-3245"],"issn-type":[{"value":"0008-6363","type":"print"},{"value":"1755-3245","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2023,1,1]]},"published":{"date-parts":[[2023,1,1]]}}}